Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 - PubMed (original) (raw)
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Byung Eui Kim et al. Clin Immunol. 2008 Mar.
Abstract
Atopic dermatitis (AD) is characterized by a defective skin barrier which allows increased allergen and pathogen penetration. Loricrin (LOR) and involucrin (IVL) are proteins important for skin barrier formation and integrity. In this study, we demonstrate that the gene and protein expression of LOR and IVL is significantly decreased in involved (LOR: p<0.001; IVL: p<0.001) and uninvolved (LOR: p<0.001; IVL: p<0.001) skin of AD subjects, as compared to skin from healthy subjects. Using primary keratinocytes, we further demonstrate the down-regulatory effect of IL-4 and IL-13--which are over-expressed in the skin of AD patients--on LOR and IVL expression in keratinocytes. Additionally, skin biopsies from signal transducer and activator of transcription (STAT)-6 transgenic mice were deficient in the expression and production of LOR and IVL. This study suggests that Th2 cytokines inhibit expression of LOR and IVL through a STAT-6 dependent mechanism.
Figures
Figure 1
Gene expression of LOR and IVL in skin from normal subjects and AD patients. RNA was isolated from the skin of 13 normal subjects and 14 patients with AD, and the gene levels of LOR (A) and IVL (B) were evaluated by real-time RT-PCR. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 1
Gene expression of LOR and IVL in skin from normal subjects and AD patients. RNA was isolated from the skin of 13 normal subjects and 14 patients with AD, and the gene levels of LOR (A) and IVL (B) were evaluated by real-time RT-PCR. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 2
Decreased LOR and IVL staining in AD skin. (A, B) Representative paraffin embedded skin biopsies from normal subjects (n = 13), and patients with AD (n = 14) stained for LOR (A) and IVL (B) are shown. Images were collected at ×400 magnification. (C, D) The intensities of the staining for LOR (C) and IVL (D) were graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 2
Decreased LOR and IVL staining in AD skin. (A, B) Representative paraffin embedded skin biopsies from normal subjects (n = 13), and patients with AD (n = 14) stained for LOR (A) and IVL (B) are shown. Images were collected at ×400 magnification. (C, D) The intensities of the staining for LOR (C) and IVL (D) were graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 2
Decreased LOR and IVL staining in AD skin. (A, B) Representative paraffin embedded skin biopsies from normal subjects (n = 13), and patients with AD (n = 14) stained for LOR (A) and IVL (B) are shown. Images were collected at ×400 magnification. (C, D) The intensities of the staining for LOR (C) and IVL (D) were graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 2
Decreased LOR and IVL staining in AD skin. (A, B) Representative paraffin embedded skin biopsies from normal subjects (n = 13), and patients with AD (n = 14) stained for LOR (A) and IVL (B) are shown. Images were collected at ×400 magnification. (C, D) The intensities of the staining for LOR (C) and IVL (D) were graded visually on a scale from 0 (no staining) to 5 (the most intense staining). *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3
Th2 cytokines down-regulate the gene expressions of LOR and IVL. Primary human keratinocytes were differentiated in the absence and presence of IL-4, IL-13 or combination of IL-4 and IL-13 for 5 days. Then RNA was isolated from the cells, and the gene expressions of LOR (A) and IVL (B) were examined by real-time RT-PCR. ***P < 0.001.
Figure 3
Th2 cytokines down-regulate the gene expressions of LOR and IVL. Primary human keratinocytes were differentiated in the absence and presence of IL-4, IL-13 or combination of IL-4 and IL-13 for 5 days. Then RNA was isolated from the cells, and the gene expressions of LOR (A) and IVL (B) were examined by real-time RT-PCR. ***P < 0.001.
Figure 4
Gene expression of LOR and IVL was decreased in STAT-6 transgenic mice. Skin biopsies were obtained from 15 wild type (C57BL/6) and 15 STAT-6 transgenic mice, and gene expression of LOR (A) and IVL (B) was evaluated using real-time RT-PCR.
Figure 4
Gene expression of LOR and IVL was decreased in STAT-6 transgenic mice. Skin biopsies were obtained from 15 wild type (C57BL/6) and 15 STAT-6 transgenic mice, and gene expression of LOR (A) and IVL (B) was evaluated using real-time RT-PCR.
Similar articles
- Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
Furue M. Furue M. Int J Mol Sci. 2020 Jul 29;21(15):5382. doi: 10.3390/ijms21155382. Int J Mol Sci. 2020. PMID: 32751111 Free PMC article. Review. - Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.
Bao L, Alexander JB, Zhang H, Shen K, Chan LS. Bao L, et al. J Interferon Cytokine Res. 2016 Jun;36(6):374-81. doi: 10.1089/jir.2015.0056. Epub 2016 Feb 26. J Interferon Cytokine Res. 2016. PMID: 26918372 Free PMC article. - A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis.
Bao L, Mohan GC, Alexander JB, Doo C, Shen K, Bao J, Chan LS. Bao L, et al. Innate Immun. 2017 Nov;23(8):641-647. doi: 10.1177/1753425917732823. Epub 2017 Sep 27. Innate Immun. 2017. PMID: 28952836 - Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J, Li Y, Fischer MJM, Steinhoff M, Chen W, Wang J. Meng J, et al. Front Immunol. 2021 Jun 30;12:696784. doi: 10.3389/fimmu.2021.696784. eCollection 2021. Front Immunol. 2021. PMID: 34276687 Free PMC article. Review.
Cited by
- Human Beta Defensin-2 mRNA and Proteasome Subunit β Type 8 mRNA Analysis, Useful in Differentiating Skin Biopsies from Atopic Dermatitis and Psoriasis Vulgaris Patients.
Terlikowska-Brzósko A, Galus R, Murawski P, Niderla-Bielińska J, Młynarczuk-Biały I, Paluchowska E, Owczarek W. Terlikowska-Brzósko A, et al. Int J Mol Sci. 2024 Aug 24;25(17):9192. doi: 10.3390/ijms25179192. Int J Mol Sci. 2024. PMID: 39273140 Free PMC article. - Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Atopic Dermatitis.
He K, Zang J, Ren T, Feng S, Liu M, Zhang X, Sun W, Chu J, Xu D, Liu F. He K, et al. J Inflamm Res. 2024 Aug 29;17:5783-5800. doi: 10.2147/JIR.S479444. eCollection 2024. J Inflamm Res. 2024. PMID: 39224661 Free PMC article. Review. - Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis.
Jia Q, Liu P, Wang X, Hu J, Jia J, Zhang J, Li H. Jia Q, et al. Arch Dermatol Res. 2024 Aug 29;316(8):585. doi: 10.1007/s00403-024-03268-7. Arch Dermatol Res. 2024. PMID: 39207509 Free PMC article. - Role of LECT2 in exacerbating atopic dermatitis: insight from in vivo and in vitro models via NF-κB signaling pathway.
Liu Z, Jiang X, Zhao K, Ruan H, Ma Y, Ma Y, Zhou Q, Zhang J, Sun X, Ma W, Xu S. Liu Z, et al. Front Immunol. 2024 Aug 14;15:1439367. doi: 10.3389/fimmu.2024.1439367. eCollection 2024. Front Immunol. 2024. PMID: 39206203 Free PMC article. - Analysis of intracellular communication reveals consistent gene changes associated with early-stage acne skin.
Deng M, Odhiambo WO, Qin M, To TT, Brewer GM, Kheshvadjian AR, Cheng C, Agak GW. Deng M, et al. Cell Commun Signal. 2024 Aug 14;22(1):400. doi: 10.1186/s12964-024-01725-4. Cell Commun Signal. 2024. PMID: 39143467 Free PMC article.
References
- Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–160. - PubMed
- Taieb A, Hanifin J, Cooper K, Bos JD, Imokawa G, David TJ, Ring J, Gelmetti C, Kapp A, Furue M, de Prost Y, Darsow U, Werfel T, Atherton D, Oranje AP. Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15–17, 2005. J Allergy Clin Immunol. 2006;117:378–390. - PubMed
- Olsson M, Broberg A, Jernas M, Carlsson L, Rudemo M, Suurkula M, Svensson PA, Benson M. Increased expression of aquaporin 3 in atopic eczema. Allergy. 2006;61:1132–1137. - PubMed
- Sator PG, Schmidt JB, Honigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol. 2003;48:352–358. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR 00051/RR/NCRR NIH HHS/United States
- R01 AR041256/AR/NIAMS NIH HHS/United States
- U01 AI147462/AI/NIAID NIH HHS/United States
- N01 AI 40030/AI/NIAID NIH HHS/United States
- N01AI40030/AI/NIAID NIH HHS/United States
- R01 AR041256-16/AR/NIAMS NIH HHS/United States
- M01 RR000051-457759/RR/NCRR NIH HHS/United States
- R21 AR051634/AR/NIAMS NIH HHS/United States
- N01 AI040029/AI/NIAID NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- N01 AI 40029/AI/NIAID NIH HHS/United States
- AR 41256/AR/NIAMS NIH HHS/United States
- R21 AR 051634-01/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous